Natalie Compton

Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial

B.J. Monk, Maria Pilar Barretina-Ginesta, Bhavana Pothuri et al. · Annals of Oncology · 2024 · 150 citations · Full text

Medicine, Oncology, Pharmacology +17

Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: Rationale for future randomised trials in human papilloma virus-negative disease

Kevin J. Harrington, A. Berrier, Martin Robinson et al. · European Journal of Cancer · 2012 · 118 citations

Medicine, Oncology, Radiation Oncology +7

Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck

J.M. del Campo, Ricardo Hitt, P. Sebastian et al. · British Journal of Cancer · 2011 · 113 citations · Full text

Medicine, Oncology, Pharmacology +17

Progression-free survival and safety at 3.5 years of follow-up: results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer

Antonio González-Martı́n, Bhavana Pothuri, Ignace Vergote et al. · European Journal of Cancer · 2023 · 112 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Geographic variation in human papillomavirus–related oropharyngeal cancer: Data from 4 multinational randomized trials

Hisham Mehanna, Natalie Franklin, Natalie Compton et al. · Head & Neck · 2016 · 62 citations · Full text

Medicine, Oncology, Cancer Epidemiology +13